Illumina, Inc. vs United Microelectronics Corp — how do they compare? Illumina, Inc. trades at $266.99 (market cap $39.95B), while United Microelectronics Corp trades at $23 (market cap $58.02B). The key difference: United Microelectronics Corp is the larger of the two by market cap, and United Microelectronics Corp pays a 1.76% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and United Microelectronics Corp for 42 Days on average.
| ILMN | UMC | |
|---|---|---|
Market Cap | $39.95B | $58.02B |
Volume | 3,169,503 | 11,897,809 |
Sector | Health | Technology |
52-Week High | $293.69 | $28.02 |
52-Week Low | $91.00 | $7.02 |
Typical Hold Time | 83 Days | 42 Days |
Enterprise Value | $41.31B | $55.10B |
Dividend Yield | — | 1.76% |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
United Microelectronics (UMC) trades at $23.31, up 0.52% with a bullish technical signal despite mixed moving averages. The company shows strong profitability with 32.75% net income margin and 21.03% ROE, though revenue growth has slowed from 2022 peaks. Recent earnings beats and positive 2026 projections suggest operational strength, while analyst consensus remains cautious with 53% hold ratings.
UMC presents a mixed outlook with strong fundamentals offset by valuation concerns. The stock's 250% annual gain creates near-term resistance, while projected 2026 earnings growth of 103% offers upside potential. Key risks include semiconductor cyclicality and AI spending volatility, requiring careful position sizing despite intrinsic value estimates near $29.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →